Back to dashboard
All PlansAdministrativeMedium impact

Voluntary medical device correction: Freestyle Libre

UPMC Health Plan·Endocrinology, Family Medicine, Internal Medicine +1 more·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Abbott has issued a voluntary medical device correction for FreeStyle Libre glucose monitoring system readers used by diabetes patients. This is a safety notice that may affect device availability and patient monitoring, potentially impacting related billing for continuous glucose monitoring services.

Action Required

Action needed
Immediately: Clinical staff should identify patients using FreeStyle Libre, FreeStyle Libre 14 Day, and FreeStyle Libre 2 systems and review the full device correction details at the provided URL. Billing team should monitor for potential changes to continuous glucose monitoring claims if device replacements or interruptions occur.